Papers

3 results
P
broilers
I/C
mycotoxins, yeast cell wall extract, control, with inclusion of yeast cell wall extract
O
body weight gain, feed intake, feed conversion ratio, mortality, carbon footprint
Urine drug testing among Medicaid enrollees initiating buprenorphine treatment for opioid use disorder within 9 MODRN states.
Hammerslag L, Talbert J, Donohue JM, Sharbaugh M, Ahrens K, Allen L, Austin AE, Gordon AJ, Jarlenski M, Kim JY, Mohamoud S, Tang L, Burns M, null null - Drug and alcohol dependence, July 07, 2023 2 citations
P
MEDICAID ENROLLEES INITIATING BUPRENORPHINE TREATMENT FOR OPIOID USE DISORDER
I/C
URINE DRUG TESTING (UDT) FOR PERSONS INITIATING BUPRENORPHINE TREATMENT FOR OPIOID USE DISORDER, VARIATION AMONG STATES IN UDT RATES AND DEMOGRAPHIC PREDICTORS OF UDT
O
PERCENTAGE OF ENROLLEES RECEIVING AT LEAST 1 UDT, AT LEAST 3 UDT, AND THE ASSOCIATION BETWEEN DEMOGRAPHICS AND UDT
Performance and environmental impact of egg production in response to dietary supplementation of mannan oligosaccharide in laying hens: a meta-analysis.
Salami SA, Ross SA, Patsiogiannis A, Moran CA, Taylor-Pickard J - Poultry science, February 27, 2022 13 citations
P
laying hens
I/C
supplementing mannan oligosaccharide (MOS), nonsupplemented diets (control)
O
production performance, egg quality attributes, carbon footprint
CEO: Hwi-yeol YunCOO: Jung-woo ChaeCTO: Sangkeun Jung
Location: 204, W6, Chungnam National University, 99, Daehak-ro, Yuseong-gu, Daejeon, Republic of Korea
Tel: 042-821-7328E-mail: webmaster@lilac-co.kr
Copyright © 2024 by LiLac. All Rights Reserved.